Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Nuvation Bio Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Nuvation Bio Inc. May 21, 2026100.0%
-
Tandem Diabetes Care Inc. May 24, 202385.2%
-
Nuvation Bio Inc. May 16, 2023100.0%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 21, 2024 | Tandem Diabetes Care Inc. | Open-market sale | −30,000 | $31.38 | $941,400 |
| Nov 20, 2024 | Tandem Diabetes Care Inc. | Open-market sale | −10,000 | $30.00 | $300,000 |
| Jun 11, 2024 | Nuvation Bio Inc. | Open-market purchase | +172,189 | $2.90 | $499,348 |
| May 24, 2024 | Tandem Diabetes Care Inc. | Option exercise | +4,434 | $51.73 | $229,371 |
| May 25, 2023 | Tandem Diabetes Care Inc. | Option exercise | +2,757 | — | — |
Questions about Kim D. Blickenstaff
What boards is Kim D. Blickenstaff on?
Kim D. Blickenstaff sits on the boards of Nuvation Bio Inc. and Tandem Diabetes Care Inc.
How long has Kim D. Blickenstaff served on boards?
Our records show at least 7 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.